JP2022510372A5 - - Google Patents
Info
- Publication number
- JP2022510372A5 JP2022510372A5 JP2021531506A JP2021531506A JP2022510372A5 JP 2022510372 A5 JP2022510372 A5 JP 2022510372A5 JP 2021531506 A JP2021531506 A JP 2021531506A JP 2021531506 A JP2021531506 A JP 2021531506A JP 2022510372 A5 JP2022510372 A5 JP 2022510372A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- form according
- mass
- virosome
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023215062A JP2024029053A (ja) | 2018-11-29 | 2023-12-20 | ビロソームを含む経口分散性ワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862772823P | 2018-11-29 | 2018-11-29 | |
| US62/772,823 | 2018-11-29 | ||
| PCT/EP2019/082940 WO2020109485A1 (en) | 2018-11-29 | 2019-11-28 | Oral dispersible vaccine comprising virosomes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023215062A Division JP2024029053A (ja) | 2018-11-29 | 2023-12-20 | ビロソームを含む経口分散性ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022510372A JP2022510372A (ja) | 2022-01-26 |
| JP2022510372A5 true JP2022510372A5 (https=) | 2022-11-29 |
| JP7408660B2 JP7408660B2 (ja) | 2024-01-05 |
Family
ID=68766733
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531506A Active JP7408660B2 (ja) | 2018-11-29 | 2019-11-28 | ビロソームを含む経口分散性ワクチン |
| JP2023215062A Pending JP2024029053A (ja) | 2018-11-29 | 2023-12-20 | ビロソームを含む経口分散性ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023215062A Pending JP2024029053A (ja) | 2018-11-29 | 2023-12-20 | ビロソームを含む経口分散性ワクチン |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11523988B2 (https=) |
| EP (1) | EP3886896B1 (https=) |
| JP (2) | JP7408660B2 (https=) |
| KR (2) | KR20210099606A (https=) |
| CN (1) | CN113301917B (https=) |
| AR (1) | AR117671A1 (https=) |
| AU (1) | AU2019389772A1 (https=) |
| CA (1) | CA3120744A1 (https=) |
| ES (1) | ES2993361T3 (https=) |
| IL (1) | IL282371B2 (https=) |
| MX (1) | MX2021006153A (https=) |
| TW (1) | TWI819156B (https=) |
| WO (1) | WO2020109485A1 (https=) |
| ZA (1) | ZA202104459B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022103639A1 (en) | 2020-11-16 | 2022-05-19 | Orcosa Inc. | Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogs |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| IL309143A (en) * | 2021-06-11 | 2024-02-01 | Orphai Therapeutics Inc | Stabilized apilimod compositions and uses thereof |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2086831C (en) | 1991-05-08 | 1999-03-16 | Reinhard Gluck | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| WO1997013531A1 (en) | 1995-10-13 | 1997-04-17 | Zynaxis, Inc. | Solid, orally administrable viral vaccines and methods of preparation |
| GB9722682D0 (en) * | 1997-10-27 | 1997-12-24 | Scherer Ltd R P | Pharmaceutical products |
| US20040265377A1 (en) | 1997-10-27 | 2004-12-30 | Harry Seager | Solid dispersing vaccine composition for oral delivery |
| AU2001234616A1 (en) * | 2000-01-31 | 2001-08-07 | Vic Jira | Vaccine composition, process and methods |
| EP1447080A1 (en) | 2003-02-13 | 2004-08-18 | Bestewil Holding B.V. | Method for producing virosome-like particles |
| AR056245A1 (es) | 2003-06-19 | 2007-10-03 | Bestewil Holding Bv | Membranas virales reconstituidas funcionales que contienen un coadyuvante |
| EP2269638A3 (en) | 2004-05-28 | 2012-06-13 | GlaxoSmithKline Biologicals S.A. | Vaccine compositions comprising virosomes and a saponin adjuvant |
| US7972621B2 (en) | 2004-06-03 | 2011-07-05 | R.P. Scherer Technologies, Llc | Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
| EP1652914A1 (en) | 2004-10-27 | 2006-05-03 | Berna Biotech AG | Virosome particles comprising antigens from influenza virus and Hepatitis B virus |
| EP1676569A1 (en) | 2004-12-30 | 2006-07-05 | Pevion Biotech Ltd. | Lyophilization of virosomes |
| EP1797895A1 (en) | 2005-12-16 | 2007-06-20 | Pevion Biotech Ltd. | An adjuvant system comprising virosomes and liposomes |
| WO2007099387A1 (en) | 2006-03-03 | 2007-09-07 | Mymetics Corporation | Virosome-like vesicles comprising gp41-derived antigens |
| AR059972A1 (es) | 2006-03-22 | 2008-05-14 | Solvay Pharm Bv | Administracion intranasal o inhalacional de virosomas |
| US20100047277A1 (en) | 2006-07-13 | 2010-02-25 | Compans Richard W | Virosomes, methods of preparation, and immunogenic compositions |
| EP2066354B1 (en) | 2006-09-29 | 2013-04-17 | Ligocyte Pharmaceuticals, Inc. | Norovirus vaccine formulations |
| EP1938835A1 (en) | 2006-12-29 | 2008-07-02 | Pevion Biotech AG | Non-specific immunostimulating agents |
| KR20100045413A (ko) | 2007-06-14 | 2010-05-03 | 크루셀 스위츨랜드 아게 | 피내 인플루엔자 백신 |
| EP2014279A1 (en) | 2007-06-22 | 2009-01-14 | Pevion Biotech AG | Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof |
| EP2058002A1 (en) | 2007-10-31 | 2009-05-13 | Bestewil Holding B.V. | Reconstituted respiratory syncytial virus membranes and use as respiratory syncytial virus vaccine |
| US9775819B2 (en) | 2009-09-16 | 2017-10-03 | R.P. Scherer Technologies, Llc | Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin |
| EP2519539A4 (en) | 2009-12-28 | 2013-11-13 | Ligocyte Pharmaceuticals Inc | METHODS FOR STABILIZING VIRUS-LIKE PARTICULATE SOLUTIONS BASED ON INFLUENZA-INFLUENZA-VIRUSED VIRUSES |
| GB201005976D0 (en) | 2010-04-09 | 2010-05-26 | Univ Aston | A freeze-dried tablet |
| JP2013542928A (ja) | 2010-09-30 | 2013-11-28 | フランバックス ソチエタ レスポンサビリタ リミテ | ビロソーム粒子の生成 |
| HUE052853T2 (hu) | 2010-10-08 | 2021-05-28 | Scherer Technologies Llc R P | Orális vakcina gyorsan oldódó dózisforma, keményítõ alkalmazásával |
| CN107625958A (zh) | 2011-05-17 | 2018-01-26 | 索利吉尼克斯公司 | 热稳定性疫苗组合物及其制备方法 |
| CN105636609A (zh) | 2013-10-25 | 2016-06-01 | 白血球保健股份有限公司 | 一种新颖的生产稳定疫苗的方法 |
| AU2014368594B2 (en) | 2013-12-19 | 2020-03-05 | Janssen Vaccines & Prevention B.V. | Improved formulations for virosomes |
| US10532093B2 (en) | 2014-07-18 | 2020-01-14 | Mds Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Thermostable freeze dried rotavirus vaccine formulation and process to prepare thereof |
| WO2016039620A2 (en) | 2014-09-12 | 2016-03-17 | Bestewil Holding B.V. | Respiratory syncytial virus virosomes |
| WO2016039619A1 (en) | 2014-09-12 | 2016-03-17 | Bestewil Holding B.V. | Methods for providing adjuvanted virosomes and adjuvanted virosomes obtainable thereby |
| WO2017047089A1 (en) | 2015-09-16 | 2017-03-23 | Shin Nippon Biomedical Laboratories, Ltd. | Vaccine compositions |
-
2019
- 2019-11-26 US US16/696,752 patent/US11523988B2/en active Active
- 2019-11-28 IL IL282371A patent/IL282371B2/en unknown
- 2019-11-28 JP JP2021531506A patent/JP7408660B2/ja active Active
- 2019-11-28 AR ARP190103479A patent/AR117671A1/es unknown
- 2019-11-28 AU AU2019389772A patent/AU2019389772A1/en active Pending
- 2019-11-28 KR KR1020217020127A patent/KR20210099606A/ko not_active Ceased
- 2019-11-28 KR KR1020237038419A patent/KR20230159621A/ko active Pending
- 2019-11-28 ES ES19813465T patent/ES2993361T3/es active Active
- 2019-11-28 EP EP19813465.2A patent/EP3886896B1/en active Active
- 2019-11-28 CA CA3120744A patent/CA3120744A1/en active Pending
- 2019-11-28 CN CN201980078668.9A patent/CN113301917B/zh active Active
- 2019-11-28 TW TW108143503A patent/TWI819156B/zh active
- 2019-11-28 WO PCT/EP2019/082940 patent/WO2020109485A1/en not_active Ceased
- 2019-11-28 MX MX2021006153A patent/MX2021006153A/es unknown
-
2021
- 2021-06-28 ZA ZA2021/04459A patent/ZA202104459B/en unknown
- 2021-08-23 US US17/409,050 patent/US11224571B2/en active Active
-
2023
- 2023-12-20 JP JP2023215062A patent/JP2024029053A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230390381A1 (en) | Immunogenic combinations | |
| US20230381301A1 (en) | Respiratory virus nucleic acid vaccines | |
| JP6827488B2 (ja) | 鼻内送達のための方法および組成物 | |
| TWI329130B (en) | Functionally reconstituted viral membranes containing adjuvant | |
| JP2022510372A5 (https=) | ||
| US20040028698A1 (en) | Vaccine | |
| JP2001524533A (ja) | 粒子状ワクチン組成物の経皮的送達 | |
| JP6564367B2 (ja) | 併用免疫原性組成物 | |
| TW202144002A (zh) | 鼻內的mRNA疫苗 | |
| JP2018172417A (ja) | 乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法 | |
| CN118695869A (zh) | 泛-肺病毒疫苗组合物及其使用方法 | |
| JP2015525794A (ja) | 乳児においてｒｓｖ及び百日咳菌に対する免疫応答を惹起するための方法 | |
| JP2003528818A (ja) | 皮膚経路を介したワクチン接種による粘膜免疫の誘導 | |
| CN113301917A (zh) | 包含病毒体的可经口分散疫苗 | |
| KR102654379B1 (ko) | 신규한 핵산을 기반으로 하는 인플루엔자 백신 조성물 | |
| EP4684796A1 (en) | Influenza vaccine composition for pulmonary delivery | |
| RU2021118721A (ru) | Перорально диспергируемая вакцина, содержащая виросомы | |
| Sahni et al. | Vaccine Delivery: current Routes of Administration and Novel Approaches | |
| Beugeling | Biodegradable implants for the biphasic pulsatile delivery of antigens: Toward single-injection vaccines | |
| WO2025231364A9 (en) | Skin-targeted ferritin nanoparticle vaccines, uses and manufacturing thereof | |
| Liu et al. | Use of novel DNA vectors and immunologic adjuvants in HIV vaccine development | |
| WO2025027616A1 (en) | Freeze-dried viral vaccine compositions and method of manufacturing thereof | |
| WO2024096743A1 (en) | Sars-cov-2 binding antibody | |
| Beukema | Intradermal administration of influenza accine ith trehalose and pullulan-based dissol ing microneedle arra s | |
| WO2023166061A1 (en) | Vaccine composition comprising an antigen and a tlr3 agonist |